I am thinking TSRX Trius therapeutics has some legs with there product getting ready to be sent off for approval, they are hiring marketing managers and other. It is around 7 dollars and options are well priced, it may be 6 months to year and half away but may be a nice pick up. Cubist would be there biggest and PFE but there product looks better than both. I say it is a buy here and hold start with 100 shares.
Yea, ASTX has came back in I though it would but I am kicking myself on ISIS, I had a few hundred shares of it about 6 months ago and let it go. I will probably put ASTX back on the radar and CRIS too but I am looking as you know for other target and I think Trius Therapeutics has a very strong candidate and I can see that stock doubling and tripling on approval or before. I really like there preclinical antibiotics as well but the current product is getting ready for FDA filing for approval.